145 related articles for article (PubMed ID: 9145852)
41. Role of cystic fibrosis transmembrane conductance regulator in pulmonary clearance of Pseudomonas aeruginosa in vivo.
Chroneos ZC; Wert SE; Livingston JL; Hassett DJ; Whitsett JA
J Immunol; 2000 Oct; 165(7):3941-50. PubMed ID: 11034402
[TBL] [Abstract][Full Text] [Related]
42. Immunization with 3-oxododecanoyl-L-homoserine lactone-protein conjugate protects mice from lethal Pseudomonas aeruginosa lung infection.
Miyairi S; Tateda K; Fuse ET; Ueda C; Saito H; Takabatake T; Ishii Y; Horikawa M; Ishiguro M; Standiford TJ; Yamaguchi K
J Med Microbiol; 2006 Oct; 55(Pt 10):1381-1387. PubMed ID: 17005787
[TBL] [Abstract][Full Text] [Related]
43. Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T-helper cell response.
Moser C; Hougen HP; Song Z; Rygaard J; Kharazmi A; Høiby N
APMIS; 1999 Dec; 107(12):1093-100. PubMed ID: 10660139
[TBL] [Abstract][Full Text] [Related]
44. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
Hogardt M; Heesemann J
Curr Top Microbiol Immunol; 2013; 358():91-118. PubMed ID: 22311171
[TBL] [Abstract][Full Text] [Related]
45. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.
Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J
FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793
[TBL] [Abstract][Full Text] [Related]
46. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease.
Rieber N; Brand A; Hector A; Graepler-Mainka U; Ost M; Schäfer I; Wecker I; Neri D; Wirth A; Mays L; Zundel S; Fuchs J; Handgretinger R; Stern M; Hogardt M; Döring G; Riethmüller J; Kormann M; Hartl D
J Immunol; 2013 Feb; 190(3):1276-84. PubMed ID: 23277486
[TBL] [Abstract][Full Text] [Related]
47. Activation of pulmonary and lymph node dendritic cells during chronic Pseudomonas aeruginosa lung infection in mice.
Damlund DS; Christophersen L; Jensen PØ; Alhede M; Høiby N; Moser C
APMIS; 2016 Jun; 124(6):500-7. PubMed ID: 27009697
[TBL] [Abstract][Full Text] [Related]
48. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
Aanæs K
J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
[TBL] [Abstract][Full Text] [Related]
49. Lentivirus-mediated overexpression of suppressor of cytokine signaling-3 reduces neutrophilic airway inflammation by suppressing T-helper 17 responses in mice with chronic Pseudomonas aeruginosa lung infections.
Ding FM; Zhang XY; Chen YQ; Liao RM; Xie GG; Zhang PY; Shao P; Zhang M
Int J Mol Med; 2018 Apr; 41(4):2193-2200. PubMed ID: 29393363
[TBL] [Abstract][Full Text] [Related]
50. Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa.
van Gennip M; Moser C; Christensen LD; Bjarnsholt T; Calum H; Jensen PØ; Christophersen L; Hougen HP; Ciofu O; Molin S; Givskov M; Høiby N
J Antimicrob Chemother; 2009 Dec; 64(6):1241-50. PubMed ID: 19815632
[TBL] [Abstract][Full Text] [Related]
51. IgG subclass antibody responses to alginate from Pseudomonas aeruginosa in patients with cystic fibrosis and chronic P. aeruginosa infection.
Pressler T; Pedersen SS; Espersen F; Høiby N; Koch C
Pediatr Pulmonol; 1992 Sep; 14(1):44-51. PubMed ID: 1437343
[TBL] [Abstract][Full Text] [Related]
52. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide.
Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY
Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264
[TBL] [Abstract][Full Text] [Related]
53. Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection.
Lang AB; Rüdeberg A; Schöni MH; Que JU; Fürer E; Schaad UB
Pediatr Infect Dis J; 2004 Jun; 23(6):504-10. PubMed ID: 15194830
[TBL] [Abstract][Full Text] [Related]
54. [Chronic Pseudomonas aeruginosa airway colonization in cystic fibrosis patients : Prevention concepts].
Dittrich AM
Internist (Berl); 2017 Nov; 58(11):1133-1141. PubMed ID: 28963697
[TBL] [Abstract][Full Text] [Related]
55. Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia.
Delaval M; Boland S; Solhonne B; Nicola MA; Mornet S; Baeza-Squiban A; Sallenave JM; Garcia-Verdugo I
Part Fibre Toxicol; 2015 Jan; 12(1):1. PubMed ID: 25605549
[TBL] [Abstract][Full Text] [Related]
56. IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia.
Buff SM; Yu H; McCall JN; Caldwell SM; Ferkol TW; Flotte TR; Virella-Lowell IL
Gene Ther; 2010 May; 17(5):567-76. PubMed ID: 20357828
[TBL] [Abstract][Full Text] [Related]
57. Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice.
van Heeckeren AM; Tscheikuna J; Walenga RW; Konstan MW; Davis PB; Erokwu B; Haxhiu MA; Ferkol TW
Am J Respir Crit Care Med; 2000 Jan; 161(1):271-9. PubMed ID: 10619831
[TBL] [Abstract][Full Text] [Related]
58. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
Banerjee D; Stableforth D
Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
[TBL] [Abstract][Full Text] [Related]
59. Novel understandings of host cell mechanisms involved in chronic lung infection: Pseudomonas aeruginosa in the cystic fibrotic lung.
Johnson PA
J Infect Public Health; 2019; 12(2):242-246. PubMed ID: 30459101
[TBL] [Abstract][Full Text] [Related]
60.
Bradshaw JL; Caballero AR; Bierdeman MA; Adams KV; Pipkins HR; Tang A; O'Callaghan RJ; McDaniel LS
mSphere; 2018; 3(3):. PubMed ID: 29720526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
